不是你母亲的激素治疗:高度选择性的雌激素受体βagonists作为下一代疗法,缓解更年期症状
Karyn M Frick1, Aaron W Fleischer1, Miranda R Schwabe1
1Department of Psychological and Brain Sciences, University of Wisconsin-Milwaukee, Milwaukee, WI 53211, United States of America.
Hormones and behavior
|June 7, 2025
概括
用选择性激动剂向雌激素受体β (ERß) 可能缓解更年期记忆功能障碍和热. 这种方法提供了雌激素治疗的潜在好处,而没有相关的健康风险.
科学领域:
- 神经内分泌学神经内分泌学
- 药理学 药理学是指药理学的学科.
- 妇女健康 妇女健康
背景情况:
- 更年期过渡会引起破坏性症状,但由于健康风险,女性避免使用雌激素治疗.
- 人们越来越了解雌激素对更年期症状 (如热和脑雾) 的作用.
- 有针对性的药物开发可以提供雌激素的好处,而没有不良影响.
研究的目的:
- 审查使用选择性激动剂向雌激素受体β (ERß) 的理由.
- 探索ERß在缓解更年期记忆功能障碍和热中的作用.
- 讨论ERß激动剂的临床试验和临床前数据.
主要方法:
- 对以雌激素为基础的绝经期荷尔蒙疗法的历史审查.
- 对雌激素调节对记忆和热的神经生物学机制的描述,重点是ERß.
- 对ERß激动剂疗效的小鼠模型的临床前数据的分析.
主要成果:
- 选择性ERß激动剂显示了增强记忆功能的潜力.
- 临床前数据表明,ERß激动剂可以减少小鼠模型中的热.
- 高效和选择性的合成ERß激动剂显示出治疗前景.
结论:
- 支持选择性ERß激动剂的有针对性的开发,以缓解更年期症状.
- 这种方法可能会为传统雌激素治疗提供更安全的替代方案.
- 进一步的研究和临床试验对于ERß激动剂疗法是有必要的.
相关概念视频
Menopause
269
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
269
Adrenergic Antagonists: ɑ and β-Receptor Blockers
642
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
642
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
228
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
228
Antidepressant Drugs: MAOIs and Other Agents
380
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
380
Adrenergic Agonists: Direct-Acting Agents
1.8K
Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
These agents can be classified...
1.8K
Hormonal Regulation of the Menstrual Cycle
729
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
729


